US stocks on Friday fell as a combination of weak economic data from China and disappointing earnings hurt technology and Internet companies, while crude oil prices fell for the 10th day in a row.
Auto sales in China last month fell for the fourth month in a row and were down 13 percent from a year earlier, the latest sign its economy is under pressure.
Concerns about China’s economy and its trade dispute with the US contributed to the global stock market skid last moth. The stocks that fared the worst during that time included tech and Internet companies, as well as retailers, which all took sharp losses on Friday.
“China has played such a critical role in driving global growth,” Invesco chief global market strategist Kristina Hooper said. “[Investors] are having concerns that these tariff wars are essentially going to kick China when it’s down.”
US crude oil slipped 0.8 percent to extend its losing streak. It has fallen for five weeks in a row and tumbled 21 percent since Oct. 3. Energy companies have suffered steep losses during that time.
Weak forecasts from firms such as video game company Activision Blizzard Inc and chipmaker Skyworks Solutions Inc also contributed to Friday’s decline.
The S&P 500 on Friday dropped 25.82 points, or 0.9 percent, to 2,781.01, but rose 2.1 percent from a close of 2,723.06 on Nov. 2.
The Dow Jones Industrial Average on Friday fell 201.92 points, or 0.8 percent, to 25,989.30, but also rose 2.8 percent from 25,270.83 a week earlier.
The NASDAQ Composite on Friday sank 123.98 points, or 1.7 percent, to 7,406.90, gaining 0.7 percent from 7,356.99 on Nov. 2.
The Russell 2000 index of smaller companies on Friday gave up 28.72 points, or 1.8 percent, to 1,549.49, edging up 0.1 percent from a close of 1,547.98 a week earlier.
The US Department of Labor reported that wholesale prices in the US jumped, which Hooper said could be linked to the tariff dispute as well.
Wholesale prices last month rose by the most in six years as gas, food and chemical prices increased. The department’s wholesale price index has climbed 2.9 percent over the past year.
Activision Blizzard tumbled after its forecast for the critical holiday season fell short of analysts’ projections. The stock fell 12.4 percent to US$55.01, while Electronic Arts Inc lost 5.3 percent to US$88.89.
Major technology and Internet companies also turned lower. Apple Inc fell 1.9 percent to US$204.47 and Facebook Inc shed 2 percent to US$144.96, while Amazon.com Inc lost 2.4 percent to US$1,712.43.
US west coast utility companies tumbled as wildfires worsened in southern California, with tens of thousands of people forced to flee their homes.
Pacific Gas and Electric Co plunged 16.5 percent to US$39.92 and Edison International skidded 12.1 percent to US$61.
General Electric Co sank another 5.7 percent to US$8.58 after a JPMorgan Chase & Co analyst cut his price target on the stock from US$10 to US$6 per share.
Six of the firm’s eight divisions might be unprofitable in 2020, Stephen Tusa said.
Walt Disney Co’s net earnings were better than expected, as the entertainment giant raked in revenue from movies including Avengers: Infinity War, Incredibles 2 and Ant-Man and the Wasp. The stock gained 1.7 percent to US$118.
Online reviews company Yelp inc nosedived after it posted weak third-quarter revenue and its forecast for the fourth quarter also fell short of Wall Street’s estimates.
Part of the problem is an advertising model that is intended to encourage advertisers to try the site without signing a long-term contract, which has made its results more sensitive to short-term problems, said Yelp, whose stock fell 26.6 percent to US$31.93.
Additional reporting by staff writer
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March